Dexterra Group (DXT) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
2 Apr, 2026Opening remarks and agenda
Meeting held virtually with voting and Q&A facilitated online.
Chair and Secretary roles confirmed; scrutineers appointed to oversee voting.
Notice of meeting and quorum confirmed; meeting declared properly constituted.
Board and executive committee updates
Nine directors nominated and elected for the coming year.
CEO Mark Becker and CFO Denise Achonu present; executive team changes planned post-modular sale.
Management uses non-GAAP measures for performance evaluation and compensation.
Chief Financial Officer contact provided for investor relations.
Overview of voting outcomes
All items of business, including director elections and auditor appointment, approved by shareholders.
Final voting results to be filed on SEDAR and released via press release.
Latest events from Dexterra Group
- Achieved $1.0B revenue and 15% ROE in 2025, with strong growth and disciplined strategy.DXT
Investor presentation - Q2 2026 revenue rose 8% to CAD 269.2M, with higher margins and strong Free Cash Flow.DXT
Q2 2026 - $1.0B revenue, 15%+ CAGR, and strong US growth ambitions define the 2026 outlook.DXT
Investor presentation - Q1 2026 revenue up 15% and adjusted EBITDA up 32%, with strong margins and positive outlook.DXT
Q1 2026 - Record financials, all proposals approved, with focus on growth, M&A, and sustainability.DXT
AGM 2025 - Strong 2025 performance, strategic acquisitions, and sustainability drive growth and returns.DXT
Corporate presentation - Record 2025 revenue, earnings, and acquisitions drive strong growth and outlook.DXT
Q4 2025 - Q2 2024 revenue grew 18.1% year-over-year, driven by WAFES and IFM gains, with higher margins.DXT
Q2 2024 - Q3 revenue up 1.5% to $269.7M, strong IFM growth, Modular business sold, outlook robust.DXT
Q3 2024